Jefferies upgrades Chemed to Buy, sees compounder multiple returning on Q3 beat

More in Finance

• Bullish on Anthropic but don’t want to wait until the IPO? Here’s how you can invest today.

  Market participants seeking access to the artificial intelligence firm can utilize specific financial instruments prior to its public listing. Current vehicles in the market enable retail and institutional buyers to secure indirect holdings. This approach bypasses the private market barrier for those wanting earlier exposure to the enterprise.

  1 min read
• Cerebras Systems drops 4% following Culper Research short report

  The chipmaker faced immediate market pressure after an activist short seller released a critical report challenging the company's valuation and business model. Investors quickly pared down exposure as the claims introduced uncertainty surrounding operational performance and near-term growth. The sudden downturn reflects growing investor sensitivity to research scrutiny in the artificial intelligence hardware sector.

  1 min read
• Crompton Greaves shares rebound 4% after recent losses: Can the beaten-down stock sustain its recovery?

  Strong quarterly earnings and favorable technical indicators are renewing investor confidence in Crompton Greaves Consumer Electricals after a prolonged downturn. The consumer goods manufacturer reported double-digit segment expansion and effective pricing actions to offset raw material inflation. Domestic brokerages have responded by reaffirming buy ratings, projecting substantial upside as operating margins recover.

  3 min read